- Home
- YSG vs LAB Comparison
YSG vs LAB Comparison
Compare YSG & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSG | LAB |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.3M | 488.4M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | YSG | LAB |
|---|---|---|
| Price | $3.88 | $0.99 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 114.1K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $18.68 | N/A |
| Revenue Next Year | $12.68 | $2.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.30 | $0.92 |
| 52 Week High | $11.04 | $1.72 |
Technical Indicators
Market Signals| Indicator | YSG | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 35.63 |
| Support Level | $3.81 | N/A |
| Resistance Level | $4.53 | $1.41 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 12.93 | 25.56 |
Price Performance
Historical ComparisonAbout YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.